• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结节性硬化症复杂型难治性癫痫的治疗可能性]

[Therapeutic possibilities in refractory epilepsy in tuberous sclerosis complex].

作者信息

Puertas-Martin Verónica, Carreras-Saez Inmaculada, Marana Ana, Ruiz-Falco Rojas M Luz, Cantarin-Extremera Verónica, Calleja-Gero M Lourdes

机构信息

Hospital Infantil Universitario Nino Jesus, 28009 Madrid, Espana.

出版信息

Rev Neurol. 2014 Jun 16;58(12):529-35.

PMID:24915028
Abstract

INTRODUCTION

Tuberous sclerosis complex (TSC) is frequently accompanied by difficult-to-treat epilepsy, which conditions these patients' quality of life and cognitive level. AIM. To describe the epidemiological and clinical characteristics, as well as the treatment of patients affected by TSC with epilepsy.

PATIENTS AND METHODS

A retrospective review was carried out of the medical records of 30 patients aged under 18 registered in our database, who had been diagnosed with TSC and epilepsy.

RESULTS

The age at onset of epilepsy in the patients with TSC in our series ranged from one month to four years. All of them began with partial crises. Two presented West's syndrome and four others had infantile spasms without hypsarrhythmia. In 19 of the patients, the epilepsy was medication resistant. As regards treatment with antiepileptic drugs, 11 are in monotherapy, 10 in bitherapy, seven in tritherapy and one with four drugs. Two were given ACTH, two carry an implanted vagal nerve stimulator, four receive treatment with everolimus and eight have undergone surgery.

CONCLUSIONS

Epilepsy is a very common problem and begins in the early years of life in TSC. There are currently a large number of therapeutic options available, although 63.3% of patients have non-controlled epilepsy and most of them present crises on a daily basis. Poor control of their crises is correlated with mental retardation and autism spectrum disorder. The positive response obtained with other therapeutic possibilities, such as mTOR pathway inhibitors, surgery and vagal nerve stimulator, should be noted.

摘要

引言

结节性硬化症(TSC)常伴有难以治疗的癫痫,这影响着这些患者的生活质量和认知水平。目的:描述结节性硬化症合并癫痫患者的流行病学和临床特征以及治疗情况。

患者与方法

对我们数据库中登记的30例18岁以下被诊断为结节性硬化症和癫痫的患者的病历进行回顾性研究。

结果

我们研究系列中结节性硬化症患者癫痫发作的起始年龄为1个月至4岁。所有患者均以部分性发作开始。2例出现韦斯特综合征,另外4例有无节律失调的婴儿痉挛。19例患者的癫痫对药物治疗耐药。在抗癫痫药物治疗方面,11例采用单药治疗,10例采用两药联合治疗,7例采用三药联合治疗,1例采用四种药物治疗。2例接受促肾上腺皮质激素(ACTH)治疗,2例植入了迷走神经刺激器,4例接受依维莫司治疗,8例接受了手术。

结论

癫痫是结节性硬化症患者早年生活中非常常见的问题。目前有大量的治疗选择,尽管有63.3%的患者癫痫未得到控制,且大多数患者每天都有发作。癫痫发作控制不佳与智力发育迟缓及自闭症谱系障碍相关。应注意其他治疗方法如mTOR通路抑制剂、手术和迷走神经刺激器所取得的积极疗效。

相似文献

1
[Therapeutic possibilities in refractory epilepsy in tuberous sclerosis complex].[结节性硬化症复杂型难治性癫痫的治疗可能性]
Rev Neurol. 2014 Jun 16;58(12):529-35.
2
Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.结节性硬化症患儿的癫痫:缓解几率及对抗癫痫药物的反应
Epilepsia. 2015 Aug;56(8):1239-45. doi: 10.1111/epi.13050. Epub 2015 Jun 4.
3
Epileptic spasms in tuberous sclerosis complex.结节性硬化症中的癫痫性痉挛。
Epilepsy Res. 2013 Sep;106(1-2):200-10. doi: 10.1016/j.eplepsyres.2013.05.003. Epub 2013 Jun 21.
4
Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.特发性婴儿痉挛症与结节性硬化症相关室管膜下巨细胞星形细胞瘤患儿接受依维莫司治疗的长期疗效及生长情况。
Eur J Paediatr Neurol. 2013 Sep;17(5):479-85. doi: 10.1016/j.ejpn.2013.03.002. Epub 2013 Apr 6.
5
Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.哺乳动物雷帕霉素靶蛋白抑制剂治疗结节性硬化症的耐药性癫痫和室管膜下巨细胞星形细胞瘤。
J Pediatr. 2014 May;164(5):1195-200. doi: 10.1016/j.jpeds.2013.12.053. Epub 2014 Feb 8.
6
Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.氨己烯酸治疗结节性硬化症患者婴儿癫痫的精神和行为结局
Epilepsy Res. 2000 Feb;38(2-3):151-60. doi: 10.1016/s0920-1211(99)00082-0.
7
[Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].[结节性硬化症相关巨细胞星形细胞瘤患者对依维莫司的反应]
Rev Neurol. 2014 Dec 1;59(11):497-502.
8
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations.与结节性硬化症相关的癫痫管理:临床建议。
Eur J Paediatr Neurol. 2012 Nov;16(6):582-6. doi: 10.1016/j.ejpn.2012.05.004. Epub 2012 Jun 12.
9
Epilepsy in TSC: certain etiology does not mean certain prognosis.结节性硬化症相关癫痫:病因明确并不意味着预后确定。
Epilepsia. 2013 Dec;54(12):2134-42. doi: 10.1111/epi.12430. Epub 2013 Nov 8.
10
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.2 岁以下结节性硬化症患者使用 mTOR 抑制剂治疗的安全性和有效性 - 一项多中心回顾性研究。
Orphanet J Rare Dis. 2019 May 3;14(1):96. doi: 10.1186/s13023-019-1077-6.